|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Intraventricular Hemorrhage (IVH) | |||||
| Bleeding in the Brain | |||||
| Prematurity | |||||
| Very Low Birth Weight Infants | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Birth Weight | |||||
| Hemorrhage | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Pathologic Processes | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| indomethacin | |||||
| placebo | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Cyclooxygenase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Gout Suppressants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| Tocolytic Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||